Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023

$ 32.50

4.7 (299) In stock

This report describes measures that people who are immunocompromised can take to prevent and treat COVID-19.

Antibodies that neutralize all current SARS-CoV-2 variants of

SARS-CoV-2/COVID-19 Toolbox – ABSA International

Summary Of Guidance For Minimizing The Impact Of COVID-19, 55% OFF

Progressive loss of conserved spike protein neutralizing antibody

Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID

Pathogens, Free Full-Text

Airway and Oral microbiome profiling of SARS-CoV-2 infected asthma

Avian Flu Diary: January 2023

Mechanisms of Disease, COVID-19

COVID-19: Current and Future Federal Preparedness Requires Fixes

Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2